Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04172597
Title A Study of Poziotinib in Patients With EGFR or HER2 Activating Mutations in Advanced Malignancies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Spectrum Pharmaceuticals, Inc
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.